rethinkTHC Search
Menu
Study breakdown

Can cannabinoids help with tremor from Parkinson's, MS, and other movement disorders?

ReviewModerate evidence
The takeaway

Cannabinoid receptors are densely concentrated in brain areas controlling movement, but clinical evidence for tremor relief remains inconclusive.

Read this if you have a movement disorder and have heard cannabis might help with tremor.

High CB1 receptor density in basal ganglia and cerebellum

What the researchers found

This review examined the potential of cannabinoid-based compounds to treat tremor associated with Parkinson's disease, multiple sclerosis, Huntington's disease, and forms of ataxia. The basal ganglia and cerebellum, brain regions central to motor control, contain high densities of cannabinoid receptors.

Anecdotal reports from cannabis users have suggested symptom improvement, prompting formal research. However, controlled studies have produced mixed results. Some preclinical work shows cannabinoids modulating motor circuits through shared molecular pathways across these diseases.

The authors concluded that while the biological rationale is promising, clinical evidence has not yet demonstrated reliable tremor reduction. They called for expanded preclinical studies with different cannabinoid compounds, followed by controlled clinical trials.

Why it matters

Tremor is one of the most disabling symptoms of movement disorders and current treatments often provide incomplete relief. If cannabinoids could be shown to reduce tremor through their action on motor control circuits, they could fill a significant gap in treatment options for millions of patients worldwide.

The numbers in context

Cannabinoid CB1 receptors are found at high density in the basal ganglia and cerebellum. The review covered tremor across 4 major motor disorder categories. Results across existing studies were described as inconclusive.

How the study worked

The researchers conducted a narrative review of published literature on cannabinoid effects in tremor-related motor disorders. They examined preclinical and clinical studies across Parkinson's disease, multiple sclerosis, Huntington's disease, and cerebellar ataxia, focusing on shared molecular mechanisms.

What this study cannot tell us

This is a narrative review, not a systematic review or meta-analysis, so study selection may not be comprehensive. Many of the studies reviewed were preclinical or uncontrolled. The authors noted that clinical trial data is largely absent for most tremor indications.

How to read the evidence

Narrative review synthesizing preclinical and limited clinical data across multiple motor disorders.

When this study was published

Published in 2015. Newer clinical trial data may have emerged since.

The bigger picture

The endocannabinoid system is deeply intertwined with motor function, which is why cannabis can affect coordination and movement. Understanding whether this system can be therapeutically targeted for tremor could open new treatment avenues. But the gap between anecdotal reports and rigorous clinical evidence remains wide.

Questions still open

  • Which specific cannabinoid compounds are most promising for different types of tremor? Could synthetic cannabinoids targeting specific receptors provide tremor relief without psychoactive effects? Why have clinical results lagged behind the preclinical promise?

Common questions

Does cannabis reduce tremor?
Anecdotal reports suggest it might for some people, but controlled studies have not consistently confirmed tremor reduction. The evidence remains inconclusive as of this review.
Why would cannabinoids affect movement?
The brain regions that control movement, including the basal ganglia and cerebellum, contain high concentrations of cannabinoid receptors, making them responsive to both endogenous and plant-derived cannabinoids.

Read the original research

Cannabinoids and Tremor Induced by Motor-related Disorders: Friend or Foe?

Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics, 12(4), 778-87

Citation

Arjmand, Shokouh; Vaziri, Zohreh; Behzadi, Mina; Abbassian, Hassan; Stephens, Gary J; Shabani, Mohammad. (2015). Cannabinoids and Tremor Induced by Motor-related Disorders: Friend or Foe?. Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics, 12(4), 778-87. https://doi.org/10.1007/s13311-015-0367-5

Explore the wider topic